Clinical trial
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
NCT01521039 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 20, 2012
- Completion date
- December 30, 2024
- Enrollment
- 259 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute graft-versus-host disease, allogeneic stem cell transplant